Palmitoylethanolamide is a fatty acid compound that may inhibit the release of pro-inflammatory mediating compounds from mast cells. This endogenous substance has been associated with effects on neuroinflammation and reduction in neuropathic pain syndromes in some clinical conditions. Palmitoylethanolamide was studied for its effect on chemotherapy-induced peripheral neuropathy.